The effect of phosphate binder therapy with sucroferric oxyhydroxide on calcification propensity in chronic haemodialysis patients: a randomized, controlled, crossover trial

BACKGROUND: Calcification propensity is associated with the risk for cardiovascular events and death in end-stage renal disease patients. Here we investigated the effect of lowering serum phosphate with oral phosphate binder therapy on calcification propensity. METHODS: We performed an open-label, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiem, Ursula, Soellradl, Ina, Robl, Bernhard, Watorek, Ewa, Blum, Sabine, Dumfarth, Alexandra, Marculescu, Rodrig, Pasch, Andreas, Haller, Maria C, Cejka, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886583/
https://www.ncbi.nlm.nih.gov/pubmed/33623689
http://dx.doi.org/10.1093/ckj/sfaa154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886583/
https://www.ncbi.nlm.nih.gov/pubmed/33623689
http://dx.doi.org/10.1093/ckj/sfaa154

Ejemplares similares